| 同期整合加量调强放疗在食管癌中的应用进展 |
| |
| 引用本文： | 王澜,王亚敏,刘丽虹,刘树堂,韩春,于金明. 同期整合加量调强放疗在食管癌中的应用进展[J]. 中华放射肿瘤学杂志, 2021, 30(11): 1216-1220. DOI: 10.3760/cma.j.cn113030-20210120-00035 |
| |
| 作者姓名： | 王澜 王亚敏 刘丽虹 刘树堂 韩春 于金明 |
| |
| 作者单位： | 河北医科大学第四医院放疗科,石家庄 050011; 山东省肿瘤防治研究院(山东省肿瘤医院) 山东第一医科大学(山东省医学科学院)放疗科,济南 250117 |
| |
| 基金项目： | 国家重点研发计划项目(2018YFC1313203);国家卫生计生委医院管理研究所项目(WJWYGS-201816) |
| |
| 摘 要： | 近年非常规分割放疗在多个系统肿瘤的治疗中日益体现出优势。同期整合加量调强放疗(SIB-IMRT)可以在一次照射过程中将不同的分割剂量传递至不同区域,实现在不增加正常组织受量前提下给予高危区域(GTV)局部追加剂量照射,其剂量学优势已得到学界广泛认可。目前,在食管癌领域SIB-IMRT的局控、生存优势、适应证人群、单次分割整合加量的上限界点仍然不明确,特就该技术在食管癌中的应用予以综述。
|
| 关 键 词： | 食管肿瘤/调强放射疗法 同期整合加量 应用进展 |
| 收稿时间： | 2021-01-20 |
Research progress on application of simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma |
| |
| Wang Lan,Wang Yamin,Liu Lihong,Liu Shutang,Han Chun,Yu Jinming. Research progress on application of simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma[J]. Chinese Journal of Radiation Oncology, 2021, 30(11): 1216-1220. DOI: 10.3760/cma.j.cn113030-20210120-00035 |
| |
| Authors: | Wang Lan Wang Yamin Liu Lihong Liu Shutang Han Chun Yu Jinming |
| |
| Affiliation: | Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong, Ji'nan 250017, China |
| |
| Abstract: | In recent years, unconventional fractionated radiotherapy has shown increasing advantages in the treatment of multiple system tumors. Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) involves the delivery of standard-fraction doses of radiotherapy to different areas, achieving the delivery of higher doses of radiotherapy per fraction to the high-risk gross tumor volume (GTV) without sacrificing the irradiation dose to the normal tissues. The dosimetric advantages of SIB-IMRT have been widely recognized. At present, the local control,survival advantage, indication population and the optimal upper limit of single fraction of SIB-IMRT for esophageal carcinoma are still unclear. This article reviews the application of SIB-IMRT in esophageal carcinoma. |
| |
| Keywords: | Esophageal neoplasm/intensity-modulated radiotherapy Simultaneous integrated boost Application progress |
|
| 点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息 |
|
点击此处可从《中华放射肿瘤学杂志》下载全文 |
|
